Clinical Trial Update: Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing ticagrelor to aspirin in patients with peripheral artery disease and type 2 diabetes; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Aspirin (Aspirin)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Peripheral Artery Disease, Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2022-03-21